Home>Topics>Funds>iShares Nasdaq Biotechnology

iShares Nasdaq Biotechnology

  1. All
  2. Commentary
  3. Fund Reports
  4. ETF Reports
  5. Headlines
  1. Fitch Rates Investitionsbank Berlin IDR 'AAA'; Outlook Stable

    Headlines

    Mon, 28 Jul 2014

    was released by the rating agency) FRANKFURT/LONDON, July 28 (Fitch) Fitch Ratings has assigned Investitionsbank Berlin ( IBB ) a Long-term Issuer Default Rating (IDR) of 'AAA', Short-term IDR of 'F1+', Support Rating of '1' and Support

  2. Conatus Pharmaceuticals: Large Upside With Attractive Risk And Income Profiles

    Headlines

    Mon, 28 Jul 2014

    By Left Banker : Since my recent retirement, I have been focusing research efforts on refining my retirement income account. Thus in my recent writings on Seeking Alpha I have emphasized retirement income strategies. In addition to that income account, I also maintain a growth portfolio. Here, I ...

  3. The Fed Calls Out Biotech... Is It Time To Sell?

    Headlines

    Thu, 24 Jul 2014

    When the world’s top central banker speaks, markets pay very close attention. Last week, Federal Reserve Chair Janet Yellen was on Capitol Hill delivering her semi-annual testimony on monetary policy. And in her remarks she stuck mostly to the script signaling that a high degree of monetary policy

  4. Today's Market: Biotech Names Rallying Today

    Headlines

    Wed, 23 Jul 2014

    larger players in the sector by buying ETFs, such as the SPDR S&P Biotech ETF (NY XBI ) and the iShares Nasdaq Biotechnology (NASDAQ: IBB ) with our preference being the SPDR S&P Biotech due to it having less exposure to the more speculative

  5. Physician payment data to be made public on September 30

    Headlines

    Tue, 15 Jul 2014

    for covered recipients. Predictably, medical industry observers are confident that the disclosures will generate substantial interest from a wide swath of the health care sector. ETFs: IBB , BIB , IRY , IXJ , BIS , DRGS Post your comment!

  6. Fed report depresses biotechs

    Headlines

    Tue, 15 Jul 2014

    Biotech shares retreat today as the group continues its downtrend that started on July 7. Shares of ( IBB -1.8% ) are down ~5% from July 3's peak of $266.43. Contributing to the sell-off is the Federal Reserve's Monetary

  7. Yellen warns on small cap and momo sector valuations

    Headlines

    Tue, 15 Jul 2014

    remain little-changed. Small caps ( IWM -0.7% ) and momentum sectors like social media ( SOCL -1.1% ) and biotech ( IBB -1.1% ) are selling off as the Fed boss says their valuations "appear to be stretched." The Q&A is underway; live blog

  8. Ebola outbreak in West Africa uncontained

    Headlines

    Fri, 11 Jul 2014

    mortality rate is as high as 90%. It is spread by close contact with the body fluids and tissues of infected people. There is no treatment or vaccine available. ETFs: BBRC , EMBB ETFs: IBB , BIB , IRY , IXJ , BIS , DRGS Post your comment!

  9. Pros And Cons Of Tactical Allocation Explained With A Real Trade

    Headlines

    Thu, 10 Jul 2014

    portfolio. This one illustrates the pros and cons of tactical allocation with a former holding: the iShares Nasdaq Biotechnology ETF ( IBB ). It is just an example; however, this trade is quite typical of the pros and cons of tactical allocation

  10. Omega Pharma reportedly mulling sale

    Headlines

    Mon, 7 Jul 2014

    Bloomberg reports that privately-held Omega Pharma N.V. is exploring a sale of the company for as much as $4B. The Belgian firm was taken private ~three years ago by the founder. ETFs: IBB , BIB , IRY , IXJ , BIS , EWK , DRGS Post your comment!

« Prev12345Next »
Content Partners